Status:
UNKNOWN
The Diagnostic Benefits of the HyperQTM System in ECG Stress Testing
Lead Sponsor:
Assuta Hospital Systems
Collaborating Sponsors:
BSP Biological Signal Processing Ltd.
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
45+ years
Phase:
PHASE3
Brief Summary
The main objective of this study is to determine the usefulness of the HyperQ™ System in improving the positive predictive value of conventional ECG stress testing. Patients who are referred for stre...
Detailed Description
The study population will comprise of 1200 patients referred to stress test in three Maccabi clinics or cardiac medical centers. All patients will perform an ECG stress test with high-frequency ECG re...
Eligibility Criteria
Inclusion
- Subject referred to stress ECG
- Subjects age ≥ 45
- Subject signed an Informed Consent form
Exclusion
- Subject with contraindications for stress ECG
- Subject with implantable pacemaker or defibrillator
- Subject with LBBB
- Subject with QRS duration ≥ 110 mSec
- Subject with Wolff-Parkinson-White Syndrome
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT00449579
Start Date
August 1 2006
End Date
October 1 2007
Last Update
April 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Silber Clinic
Kfar Saba, Israel